⌘K

Login Start Free

Home/Filings/4/0001415889-25-002824

4//SEC Filing

SIEGALL CLAY B 4

Accession 0001415889-25-002824

CIK 0001472012other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 9:01 PM ET

Size

4.8 KB

Accession

0001415889-25-002824

Insider Transaction Report

Form 4

Period: 2025-01-31

Immunome Inc.IMNM

DirectorPresident and CEO

Transactions

Purchase
Common Stock
2025-01-31$7.75/sh+150,000$1,162,500→ 669,636 total

Footnotes (1)

[F1]The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock.

Documents

1 file

4
form4-02042025_020240.xmlPrimary

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1

filerCIK 0001167496

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 9:01 PM ET
Size: 4.8 KB

View on SEC.gov